Skip to main content

Table 2 Tumor characteristics, type of surgery, adjuvant treatment and survival outcomes by mode of breast cancer detection

From: Molecular profiles of screen detected vs. symptomatic breast cancer and their impact on survival: results from a clinical series

 

MODE OF DETECTION

 
 

SYMPTOMATIC

SCREEN DETECTED

P-VALUE

TUMOR CHARACTERISTICS

No.

%

No.

%

 

TOTAL

334

74.5

114

25.5

 

Tumor size

    

<.0001

  T1

166

51.7

84

80.8

 

  T2

123

38.3

19

18.3

 

  T3–T4

32

10.0

1

1.0

 

No. of positive Lymph nodes

    

.01

  All lymph nodes negative

167

52.8

73

70.2

 

  1–3

77

24.4

20

19.2

 

  4–9

52

16.5

9

8.7

 

  ≥10

20

6.3

2

1.9

 

Histological grade

    

<.0001

  1

23

7.2

20

18.5

 

  2

120

37.7

49

45.4

 

  3

175

55.0

39

36.1

 

Immunoistochemical characteristics

     

ER status

    

.11

  Positive

236

70.7

88

77.2

 

  Negative

98

29.3

26

22.8

 

PR status

    

.04

  Positive

227

68.0

89

78.1

 

  Negative

107

32.0

25

21.9

 

Ki-67

    

.02

  ≤20%

141

44.1

60

57.1

 

  >20%

179

55.9

45

42.9

 

HER2 status

    

.96

  0, 1+

227

70.1

76

70.4

 

  2+

46

14.2

16

14.8

 

  3+

51

15.7

16

14.8

 

Molecular Subtypes

    

.04

  Luminal A

193

59.0

74

68.5

.09

  Luminal B

59

18.2

18

16.7

.71

  Non-Luminal HER2+

38

11.0

14

13.0

.79

  No Basal-like

18

5.6

2

1.8

.01

  Basal-like

16

4.9

0

  

TREATMENT CHARACTERISTICS

     

Type of surgery

    

.005

  Conservative

242

74.7

88

88.0

 

  Mastectomy

82

25.3

12

12.0

 

Adjuvant Therapy

    

.04

  None

36

11.8

15

13.6

 

  Radiation only

64

21.1

37

33.6

 

  Chemotherapy only

33

10.9

8

7.3

 

  Radiation and Chemotherapy

171

56.2

50

45.5

 

Hormone given

244

81.3

92

83.6

.23

OUTCOME CHARACTERISTICS

     

Vital status

    

<.0001

  Alive, no evidence of disease

226

69.7

100

88.4

 

  Alive with this cancer

40

12.3

5

4.4

 

  Dead, no evidence of disease

4

1.2

0

-

 

  Dead from this cancer

54

16.6

8

7.0

 

  Recurrence type

    

.001

  None

230

71

100

88.5

 

  Loco-Regional

18

5.6

3

2.7

 

  Distant

76

23.5

10

8.8

 
  1. Abbreviations: BC, breast cancer; Subtypes: Luminal A (ER+ and/or PR+) and HER2-; Luminal B (ER+ and/or PR+) and HER2+; Non-Luminal HER2+ (ER- and PR-) and HER2+; Triple Negative (ER-, PR- and HER2-).
  2. Abbreviations: BC, breast cancer.